Merck - Health Xplore

Sign In

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com

Tag: Merck

Lupin Launches Sugammadex Injection in US Following FDA Approval

News

Lupin Introduces Generic Sugammadex Injection to US Following FDA Approval

Bioequivalent to Merck’s Bridion injection, Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and paediatric patients aged 2 years and older undergoing surgery.

imphoenix82
July 31, 2026
0 Comments
47 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email: support@healthxploreindia.com

Contact: +91 8447496924

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: Merck

Lupin Introduces Generic Sugammadex Injection to US Following FDA Approval

US FDA Licenses Ezplaz, First Freeze-Dried Plasma for.

Johnson & Johnson’s HNSCC Therapy Receives FDA Priority.

WHO Unveils First Global Regulatory Framework for Greener.

Lupin Introduces Generic Sugammadex Injection to US Following.

About Us

Quick Link

Top Categories

Top Posts

Laser Treatments for Anti-aging: Types, Benefits,

Lilly’s Retatrutide Shows Powerful Weight Loss

National Registry for Implantable Medical Devices: